Toritz 100 mg Injection
  1. Home
  2. Pharma Products
  3. Torrent Pharmaceuticals Ltd
  4. Toritz 100 mg Injection

Toritz 100 mg Injection

Toritz 100 mg Injection contains rituximab 100 mg, a monoclonal antibody that targets CD20-positive B cells. It is used for certain blood cancers and selected autoimmune conditions under specific treatment protocols. The medicine is administered by intravenous infusion by a qualified healthcare professional.

BUY NOW

Category

Rituximab binds to the CD20 antigen on B lymphocytes and helps eliminate these cells through immune-mediated mechanisms. Toritz is used in specific treatment regimens for conditions including non-Hodgkin lymphoma and other approved rituximab-responsive conditions. The 100 mg presentation contains 100 mg of rituximab in 10 mL, corresponding to a concentration of 10 mg/mL. Treatment dosage and infusion schedule are determined by the treating physician according to the patient’s condition and prescribed protocol.

Technical Specification

Specification Details
Active Ingredient Rituximab
Strength 100 mg
Dosage Form Solution for Injection
Concentration 10 mg/mL
Volume 10 mL
Manufacturer Torrent Pharmaceuticals Ltd

Product Also Known As

Toritz 100 mg Injection, Toritz 100mg Injection, Rituximab 100 mg Injection, Rituximab 100 mg/10 mL Injection, Rituximab Infusion, Anti-CD20 Monoclonal Antibody, Rituximab Anticancer Injection

Related products